BioAffinity Technologies Inc (NASDAQ: BIAF) flaunted slowness of -8.82% at $0.31, as the Stock market unbolted on Thursday, before settling in for the price of $0.34 at the close. Taking a more long-term approach, BIAF posted a 52-week range of $0.16-$2.99.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company of the Healthcare sector’s yearbook sales growth during the past 5- year span was recorded -10.71%. Meanwhile, its Annual Earning per share during the time was -10.71%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 46.67%. This publicly-traded company’s shares outstanding now amounts to $28.46 million, simultaneously with a float of $20.60 million. The organization now has a market capitalization sitting at $8.83 million. At the time of writing, stock’s 50-day Moving Average stood at $0.2880, while the 200-day Moving Average is $0.8125.
BioAffinity Technologies Inc (BIAF) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the BioAffinity Technologies Inc industry. BioAffinity Technologies Inc’s current insider ownership accounts for 27.61%, in contrast to 1.80% institutional ownership.
BioAffinity Technologies Inc (BIAF) Earnings and Revenue Records
BioAffinity Technologies Inc’s EPS increase for this current 12-month fiscal period is 46.67% and is forecasted to reach -0.18 in the upcoming year.
BioAffinity Technologies Inc (NASDAQ: BIAF) Trading Performance Indicators
Let’s observe the current performance indicators for BioAffinity Technologies Inc (BIAF). It’s Quick Ratio in the last reported quarter now stands at 0.53. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 1.00.
In the same vein, BIAF’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.72, a figure that is expected to reach -0.10 in the next quarter, and analysts are predicting that it will be -0.18 at the market close of one year from today.
Technical Analysis of BioAffinity Technologies Inc (BIAF)
Now, what If we examine the latest scores posted by [BioAffinity Technologies Inc, BIAF]. During the last 5-days, its volume was lower the volume of 7.93 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 44.41% While, its Average True Range was 53.80%.
Raw Stochastic average of BioAffinity Technologies Inc (BIAF) in the period of the previous 100 days is set at 10.53%, which indicates a major fall in contrast to 37.50% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.0534 that was lower than 0.0750 volatility it exhibited in the past 100-days period.
